Location History:
- Maharashtra, IN (2022)
- Dhanbad, IN (2020 - 2024)
Company Filing History:
Years Active: 2020-2025
Title: Innovations by Om Sharma in Pharmaceutical Research
Introduction
Om Sharma is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical research, holding a total of four patents. His work focuses on developing innovative systems and methods that enhance the identification of potential targets for pharmaceutical compounds.
Latest Patents
One of Om Sharma's latest patents is a "System and method for identifying potential targets for pharmaceutical compound." This invention includes a database arrangement that stores existing data sources and information related to pharmaceutical compounds. The processing module is designed to receive information about the pharmaceutical compound, extract a plurality of targets from existing data sources, analyze the druggability of each target, and designate those with a net score above a predefined threshold as potential targets.
Another significant patent is for "Phosphoinositide 3-kinase and Src inhibitors for treatment of pancreatic cancer." This invention involves a phosphoinositide 3-kinase inhibitor used in treating pancreatic cancer, along with a method for administering this inhibitor and an Src inhibitor to patients in need. The patent also includes a pharmaceutical composition that combines both inhibitors.
Career Highlights
Om Sharma is currently employed at Innoplexus AG, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving treatment options for serious health conditions, particularly cancer.
Collaborations
Om Sharma collaborates with talented professionals in his field, including Gaurav Tripathi and Vatsal Agarwal. Their combined expertise contributes to the advancement of pharmaceutical research and development.
Conclusion
Om Sharma's contributions to pharmaceutical research through his innovative patents demonstrate his dedication to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of critical diseases.